Michael Aaron Lalezarian

Michael Lalezarian practices at Prosurgical Center in Los Angeles, California.

Michael Lalezarian's NPI, 1023245230, was assigned on June 15, 2009. Michael Lalezarian graduated from David Geffen School of Medicine at UCLA in 2008. Michael Lalezarian's California license number on file is A109360.

Michael Lalezarian's primary practice is Prosurgical Center, at 127 N Gardner St, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (310) 906-2270.

Michael Lalezarian's primary practice is Prosurgical Center in Los Angeles, California. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Michael Lalezarian to 8 more medical groups, 6 group practices and clinics, 2 home health agencies and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Lalezarian practices, 9 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Michael Lalezarian's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Michael Lalezarian is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Michael Lalezarian's licenses on file in 4 states: California, Hawaii, Arizona and Texas.

CMS data shows 2,698 Medicare services from Michael Lalezarian across 22 procedure codes in 2024, for 263 Medicare patients. Medicare paid $1,638,387 for them. Every service was in an office.

CMS counts 263 Medicare patients who saw Michael Lalezarian in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 3.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Lalezarian's median patient age at 72, with 50% women.

In 2024, Michael Lalezarian wrote 226 Medicare Part D claims for 91 patients. 38% of them were for generic drugs. CMS names the drug for 175 of them, across 3 drugs with 11 or more claims each, at $138,143 in total drug cost. In 2023, CMS named 112 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Michael Lalezarian for performance year 2024, reported as part of a group. Michael Lalezarian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Lalezarian as offering telehealth. CMS counts 144 procedures of leg revascularization (restoring blood flow) by Michael Lalezarian, more than 99% of the clinicians it reports for that procedure.

CMS Open Payments shows 478 general payments to Michael Lalezarian from 32 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 50% of the total. AngioDynamics, Inc. paid the most, $45,593.

Michael Lalezarian graduated from David Geffen School of Medicine at UCLA in 2008.

Michael Lalezarian is in network with 19 carriers, including Elevance, United Healthcare and Aetna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.